Hold Rating on DENTSPLY SIRONA Amid Management Stabilization and Growth Uncertainties

Analyst Allen Lutz from Bank of America Securities maintained a Hold rating on DENTSPLY SIRONA (XRAY – Research Report) and keeping the price target at $17.00.

Allen Lutz has given his Hold rating due to a combination of factors surrounding DENTSPLY SIRONA’s current situation. The recent appointment of Matthew Garth as the new CFO is seen as a positive step towards stabilizing the company’s management, which has experienced significant turnover in recent years. This appointment is expected to enhance the company’s ability to execute its strategic initiatives effectively.
Despite the positive development in management, there remain uncertainties regarding growth in key segments such as Connected Technology Solutions and Orthodontics. Although the company’s valuation is considered relatively undemanding, these uncertainties contribute to the decision to maintain a Neutral rating. The price objective is set at $17, slightly above the current price of $16.33, indicating limited upside potential in the near term.

Based on the recent corporate insider activity of 89 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of XRAY in relation to earlier this year.